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Abstract
Background: Coronary artery disease is very common in Pakistani population. Some of the studies carried out on Western
populations have shown a relationship between body iron status as determined by the ratio of concentrations of serum
soluble transferrin receptor (sTfR) to ferritin and the risk of acute myocardial infarction (AMI). In order to investigate whether
increased body iron status has any relationship with the risk of premature AMI in Pakistani population, a case-control study
was carried out.
Methodology/Principal findings: In this case-control study, 203 consecutive AMI patients [146 males and 57 females; age
range 18–45 years] admitted to the National Institute for Cardiovascular Diseases, Karachi, were enrolled with informed
consent. In addition, 205 healthy controls whose gender and age (within 3 years) matched the patients, and who had a
similar socio-economic background were recruited. Fasting venous blood was obtained and assessed for plasma/serum
folate, vitamin B12, homocysteine, total cholesterol, triglycerides, LDL-cholesterol, HDL-cholesterol, sTfR and ferritin and
blood lead. It was found that serum concentration of ferritin and blood lead levels were significantly higher in AMI patients
compared to their age and gender-matched healthy controls (p value ,0.05), while the concentrations of vitamin B12 and
HDL-cholesterol were significantly lower in AMI patients compared to controls (p value ,0.01). The ratio of sTfR to ferritin
was significantly lower in AMI patients compared to controls [mean6SD/median (IQR) values 84.76295/28.9 (38.4) vs
2556836/49.4 (83.8), respectively; p value ,0.001]. Compared with the highest quartile of sTfR/ferritin (low body iron
status), the OR for the risk of AMI was 3.29(95% CI, 1.54–7.03) for the lowest quartile (quartile 1) when the model was
adjusted for vitamin B12 and HDL-cholesterol (p value for trend ,0.01).
Conclusions/Significance: This study shows a positive association between total body iron status and risk of premature AMI
in a Pakistani population.
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this regard, the concentration ratio of sTfR to ferritin was
considered to be ‘‘a state-of-the-art measurement of the body iron
stores’’ [2]. This study carried out in Finland showed that sTfR to
ferritin ratio was associated with initial acute myocardial infarction
(AMI) [2].
CHD is the leading cause of death in the South Asian
subcontinent [3]. The major factors contributing to the development of CHD at early age include dyslipidemia, physical
inactivity, hyperhomocysteinemia and genetic, environmental
and nutritional factors [3].
Few studies have been carried out to investigate the relationship
of serum ferritin and risk of CHD in the South Asian region [4,5];
however, none of them have focused on the entire spectrum of

Introduction
Body iron because of its ability to induce oxidative stress has
been considered to be contributing to the pathogenesis of coronary
artery disease (CAD). A number of studies carried out to ascertain
the relationship between body iron stores and the risk of CAD
have yielded conflicting results. A systematic review of the
literature on this subject revealed that five studies reported
significant association between serum ferritin and coronary heart
disease (CHD), while nine studies did not show any such
relationship [1]. Most of these studies used serum ferritin as a
marker of body iron stores. Determination of serum soluble
transferrin receptor (sTfR) concentration along with serum ferritin
provided a more reliable tool for estimation of body iron status. In
PLOS ONE | www.plosone.org
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detection for serum/plasma ferritin, sTfR, folate, total cholesterol,
HDL-cholesterol, LDL-cholesterol, triglycerides, vitamin B12 and
homocysteine were 0.5 ng/mL, 0.068 mg/mL, 0.64 ng/mL,
9.7 mg/dL, 3.0 mg/dL, 3.9 mg/dL, 8.9 mg/dL, 50 pg/mL,
and 4 mmol/L, respectively. The minimum level of detection of
blood Pb in the above mentioned method was 1 mg/dL.

body iron stores employing the ratio of sTfR to ferritin and
investigating its relationship with premature CAD. Therefore, the
present study was undertaken to find out whether or not iron body
stores are associated with the risk of premature AMI in a hospitalbased Pakistani population. Since Pakistani urban population has
been found to have high levels of blood lead (Pb) which is also
associated with hyperhomocysteinemia [6], another objective of
the study was to investigate if high blood Pb levels in this
population would modulate the relationship (if any) between body
iron stores and risk of premature AMI.

Statistical Analysis
All statistical analyses were carried out using IBM Statistical
Package for Social SciencesH (SPSS) software version 19 for
WindowsH (Apache Software Foundation, USA). Independent
sample t test was used to compare mean6SD values of continuous
variables (serum folate, vitamin B12, total cholesterol, LDLcholesterol, HDL-cholesterol, triglycerides, blood Pb) between
cases and controls. However, Mann-Whitney U test was used to
compare the distributions of homocysteine, ferritin, sTfR and
sTfR/ferritin because the data for these variables were not
normally distributed. Similarly, analysis of variance (ANOVA) was
used to compare the mean values of continuous variables across
the sTfR/ferritin quartiles, while Kruskal-Wallis nonparametric
test was applied for comparing the distributions of homocysteine,
sTfR and ferritin.
Conditional logistic regression was applied to examine the risk
of AMI and sTfR/ferritin. Pairwise matching resulted in 201 casecontrol pairs. The model was adjusted for vitamin B12, HDLcholesterol and blood Pb. For studying the interactions between
body iron status and classical risk factors for AMI such as diabetes
mellitus and low HDL-cholesterol (levels less than 35 mg/dL), the
model was adjusted for fasting serum glucose concentration
.126 mg/dL and low HDL-cholesterol. A p value of ,0.05 was
considered significant.

Methods
Ethics Statement
This study protocol was approved by the Ethics Review
Committee of the Aga Khan University, and a prior written
informed consent was obtained from all the study participants.

Participants’ Enrollment
In this case-control study, 203 consecutive adult patients (146
males and 57 females; age range 18–45 years) admitted to the
National Institute of Cardiovascular Diseases a public sector
institution for treatment of cardiovascular diseases in Karachi,
who met the inclusion criteria were enrolled with informed
consent. The enrollment started on November 2, 2009 and ended
on May 18, 2011. The criteria for premature AMI patients
included both male and female who were less than 45 years old
and had a confirmed diagnosis of AMI. Confirmation of diagnosis
was based on WHO criteria of clinical history suggestive of
myocardial ischemia; ECG indications of myocardial damage and
elevation of biochemical markers (creatine kinase and troponin I).
They had not taken B vitamins (B6, B12 and folic acid) and iron
supplements for the last 4 months (self-report); had no history of
malabsorption syndrome, cancer, liver disease or uremia; and
were not pregnant. In addition, 205 gender and age (within 3
years)-matched healthy individuals from the personnel of the Aga
Khan University and other healthcare institutions of Karachi, who
belonged to a similar socio-economic strata were included in the
study with informed consent as controls. These individuals also
had no history of consuming B vitamins (B6, B12 and folic acid)
and iron supplements during the last 4 months, or suffering from
malabsorption syndrome, cancer, liver disease, uremia or diabetes
mellitus; and were not pregnant. These control subjects were
included after clinical examination and relevant biochemical data.
Both patients and controls belonged to the low income group as
90% of cases and 83% of controls had monthly house-hold income
less than US $ 150. Anthropometric measurements which included
height and weight were carried out by a trained research associate.

Results
Analysis of the data revealed that concentrations of serum
vitamin B12, total cholesterol, LDL-cholesterol, HDL-cholesterol
and triglycerides were significantly lower in AMI patients
compared to age and gender-matched healthy controls (Table 1).
However, serum ferritin levels and blood Pb levels were
significantly higher in AMI patients as compared to controls (p
value ,0.001 and p value = 0.011, respectively). In addition, it was
found that the ratio of sTfR to ferritin was significantly lower in
AMI patients compared to healthy controls (p value ,0.001,
Table 1). Moreover, the ratio of sTfR to ferritin had a statistically
significant correlation with serum HDL-cholesterol (r = 0.145; p
value = 0.003). Table 2 shows serum/plasma concentrations of
homocysteine, folate, vitamin B12, cholesterol, LDL-cholesterol,
HDL-cholesterol, triglycerides, and blood Pb by quartiles of ratio
of sTfR to ferritin. Significant dose-response relationship exists for
mean values of serum HDL-cholesterol across quartiles of ratio of
sTfR to ferritin (p value = 0.004). We also found some significant
results for serum folate, total cholesterol and triglycerides;
however, dose-response relationship was not observed for these
biomarkers across quartiles of ratio of sTfR to ferritin.
In order to evaluate the risk of premature AMI across the
quartiles of ratio of sTfR to ferritin, conditional logistic regression
analysis was carried out while adjusting for vitamin B12 and HDLcholesterol. Compared to quartile 4 (reference) with the highest
ratio of sTfR to ferritin (low body iron stores), the risk of
premature AMI increases with each low quartile and a clear cut
dose-response relationship is observed from highest quartile (low
body iron stores) to lowest quartile (high body iron stores) [OR,
3.29(95% CI, 1.54–7.03); p value for trend ,0.01; Table 3]. The
risk of AMI remained more than 3 fold in individuals in the lowest

Blood Sampling and Measurement of Biomarkers
Fasting venous blood (10 ml) was collected equally in both
heparinized and nonheparinized tubes within 24 hours of hospital
admission. Measurement of blood Pb was carried out in whole
blood on graphite furnace using Hitachi Z-8000 Atomic Absorption Spectrometer with Zeeman’s background correction at the
laboratories of the Pakistan Council for Scientific and Industrial
Research, Karachi, Pakistan. Determination of serum concentration of vitamin B12 was carried out using a radioassay [7], while
plasma homocysteine concentration was examined using an
immunoassay-based kit, following the manufacturer’s instructions
(Abbott Laboratories Ltd; Pakistan). Determination of serum
ferritin, sTfR, folate, total cholesterol, triglycerides, LDL-cholesterol and HDL-cholesterol was carried out using kits obtained
from Roche Diagnostics, USA. The minimum concentrations of
PLOS ONE | www.plosone.org
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Table 1. Demographic characteristics, anthropometric measurements, and concentrations of biomarkers in patients with
premature AMI and healthy controls.

Patients

Controls

(n = 203)

(n = 205)

Males

146(71.9)

148(72.2)

Females

57(28.1)

57(27.8)

0.95

Age(Years)

41.664.5/43.0(5.0)

41.364.7/42.0(5.0)

0.51

BMI, kg/m2

25.763.6/25.1(4.8)

25.9964.9/25.5(6.2)

0.53

Characteristics*

p value**

Gender, n(%)
0.95

Homocysteine, mmol/L

23.2617.4/18.6(9.5)

23.45618.6/18.6(9.1)

0.78

Serum folate, ng/mL

6.9263.77/5.7(4.6)

6.8963.72/6.1(4.8)

0.94

Serum vitamin B12, pg/mL

3156188/276(230)

3646180/331(230)

0.007

Blood lead, mg/dL

16.366.94/14.6(9.5)

14.467.7/12.7(8.3)

0.011

Ferritin, ng/mL

158.76136.7/128.9(141.9)

87.1674.7/66.7(86.8)

,0.001

sTfR, mg/mL

3.7061.70/3.20(1.50)

4.1462.91/3.45(1.60)

0.6

sTfR/Ferritin

84.76295/28.9(38.4)

2556836/49.4(83.8)

,0.001

Total cholesterol, mg/dL

152646/150(63)

171634/170(47)

,0.001

Triglycerides, mg/dL

125658/114(70)

154693/131(97)

,0.001

LDL-cholesterol, mg/dL

98639/94(53)

105633/103(47)

0.023

HDL-cholesterol, mg/dL

28.2611.3/27.0(11.0)

38.068.0/37.0(11.0)

,0.001

*Values are mean6SD/median (IQR) except for gender which are presented as n(%).
**p value was obtained by comparing mean6SD values using Independent sample t test, however, Mann-Whitney U test was used to compare distributions for
variables homocysteine, ferritin, sTfR and sTfR/ferritin.
BMI = body mass index, sTfR = soluble transferrin receptor.
doi:10.1371/journal.pone.0067981.t001

(levels less than 35 mg/dL) is another major risk factor of AMI in
Pakistani population [9]. When the interactions of low HDLcholesterol and fasting serum glucose levels greater than 126 mg/
dL with body iron status were examined, they were found to be
nonsignificant in this regression model (p values for interactions = 0.41 and 0.46, respectively).

quartile of sTfR to ferritin when the model was also adjusted for
blood Pb [p value for trend = 0.912; Table 3]. Since diabetes
mellitus is a well-established risk factor for MI in South Asia [8],
the above mentioned logistic regression model was also adjusted
for individuals having serum glucose levels greater than 126 mg/
dL. Even after this adjustment, the odds (2.47) of having
premature AMI remained significant (p value for trend = 0.027;
Table 3) with the lowest quartile. Similarly, low HDL-cholesterol

Table 2. Serum/plasma concentrations of homocysteine, folate, vitamin B12, cholesterol, LDL-cholesterol, HDL-cholesterol,
triglycerides and blood Pb by quartiles of ratio of sTfR to ferritin in Pakistani patients with premature AMI.

Characteristics*

Q1

Homocysteine, mmol/ 23.9620.7/18.2(9.7)
L
Folate, ng/mL

7.4563.83/6.39(5.34)

Vitamin B12, pg/mL 3156159/294(219)
Cholesterol, mg/dL

155639/152(64)

Q2

Q3

Q4

p value**

22.0614.5/18.2(10)

24.2618.4/19.4(8.3)

23.0615.8/18.4(402)

0.41

6.4863.56/5.62(4.17)

6.2363.42/5.1(4.5)

7.5064.02/6.84(5.04)

0.03

3246181/300(255)

3526193/334(200)

3726203/334(248)

0.11

169645/164(51)

166640/168(52)

157641/156(52)

0.026

LDL-cholesterol, mg/ 98.3635.1/91.0(55.1)
dL

108.0639.7/105.0(51.0)

104.6635.2/105.2(47.9)

97.2635.3/93.0(46.3)

0.11

HDL-cholesterol, mg/ 30.268.4/29.0(12.0)
dL

32.9613.6/32.0(12.0)

33.9610.4/34.5(11.3)

35.7610.3/36.0(15.8)

0.004

Triglycerides, mg/dL 126.7662.4/115(73.0)

158.7695.4/129.0(89.0)

148.6680.7/132.0(86.0)

126.1666.5/111.0(69.0)

0.004

Blood Pb, mg/dL

15.166.6/14.0(7.5)

14.566.4/13.5(8.8)

14.967.6/13.0(8.4)

0.14

16.868.6/13.7(11.9)

*Values are means6SD/median (IQR).
**p value was based on ANOVA comparing means of quartiles; however, Kruskal-Wallis nonparametric test was applied for comparing the distributions for
homocysteine,
sTfR = soluble transferrin receptor.
doi:10.1371/journal.pone.0067981.t002
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Table 3. Risk of premature AMI in Pakistani adults with quartiles of ratio of sTfR to ferritin.

Crude

1

Q1

Q2

Q3

Q45

p value for trend
,0.01

4.01(2.11–7.61)**

2.70(1.40–5.12)**

1.20(0.64–2.25)

1

Adjusted2

3.29(1.54–7.03)**

3.08(1.38–6.89)**

1.21(0.57–2.57)

1

,0.01

Adjusted3

3.26(1.52–7.00)**

3.10(1.39–6.94)**

1.21(0.57–2.57)

1

0.912

Adjusted4

2.47(1.29–8.16)*

3.24(1.29–8.16)*

1.11(0.46–2.69)

1

0.027

1

Values are matched OR (95% CI) from conditional logistic regression.
Values are matched OR (95% CI) from conditional logistic regression adjusted for vitamin B12 and HDL-cholesterol.
3
Value are matched OR(95%CI) from conditional logistic regression adjusted for vitamin B12, HDL-cholesterol and blood Pb.
4
Values are matched OR (95% CI) from conditional logistic regression after adjusting for blood Pb, vitamin B12, HDL-cholesterol and fasting serum glucose levels
.126 mg/dL.
5
Considering the hypothesis that risk of premature AMI would be more at low ratio of sTfR to ferritin, the quartile indicating the highest ratio was taken as reference.
*p value ,0.05.
**p value,0.001.
doi:10.1371/journal.pone.0067981.t003
2

one of the major sources of body iron, it is conceivable that high
intake of red meat by Pakistani population could be one of the
factors contributing to the high body iron status and thus increased
risk of AMI.
Pb pollution is a problem in this part of the world [30]. Body
iron status can influence Pb absorption [31]. Therefore, we also
measured blood Pb levels in cases and controls. AMI patients in
this study had significantly high levels of blood Pb compared to
controls which is in line with previous reports showing association
between blood Pb levels and increased risk of cardiovascular
disease [32]. However, when we adjusted our regression model for
blood Pb levels, the risk of AMI remained similar to the risk when
the adjustment was made for vitamin B12 and HDL-cholesterol.
This indicates that body iron status in this population is associated
with the risk of AMI independent of blood Pb levels.
According to the INTERHEART Study, the risk of MI among
South Asians increases 2.48 folds in presence of diabetes mellitus
[8]. In the present study, even adjusting for those individuals
having fasting serum glucose levels greater than 126 mg/dL (a cut
off level for diagnosis of diabetes mellitus), the risk of premature
AMI remained nearly 2.5 fold high in those having highest iron
stores of the body compared to those with lowest body iron stores.
This also suggests that high body iron could be an independent
risk factor for premature CAD.
Ideally, our controls should have been selected from the same
communities to which AMI patients belonged. We recruited most
of our controls from the personnel of various healthcare centers in
Karachi; however, every attempt was made to pick those with
socio-economic background similar to that of AMI patients. Both
cases and controls belonged to the low income group as 90% of
patients and 83% of controls had monthly house-hold income less
than US $ 150.
There could be several reasons for increased body iron status in
Pakistani AMI patients. Ninety-nine percent of Karachi population is nonvegetarian [33], therefore high consumption of foods
rich in iron such as red meat, liver, kidney, heart, shellfish, clams,
oyster, eggs could be contributing to high iron stores [34].
Moreover, foods cooked in cast iron pots and regular exposure to
tobacco smoke must also be adding to the body iron [35].
Although our questionnaire did have information about consumption of red meat, poultry, fish and eggs, it did not include
information about consumption of other food items rich in iron
such as, shellfish, clams, oysters, nuts, seeds, or the nature of
cooking pots and the extent of an individual’s exposure to tobacco
smoke. This could be regarded as one of the limitations of this

Discussion
The relationship between body iron stores and risk of CHD,
first proposed by Sullivan in 1981 [10], remained ignored until the
results of Kuopio Ischemic Heart Disease Risk study (KIHD),
carried out in Finland, became known to the scientific community
[11]. In this study, a linear association between serum ferritin
concentration and the increased risk of heart attack was shown in
men [11,12]. A strong epidemiological evidence regarding the role
of body iron stores in carotid atherogenesis in Austrian men and
women provided further support to the Sullivan hypothesis [13].
In a study carried out in Rotterdam, elevated levels of serum
ferritin were found to be associated with the increased risk of MI in
elderly population [14]. In a case control study involving 145
Indian men, serum ferritin levels were found to be directly
correlated with the increased risk of AMI [4]. However, there were
several other studies which found no association between body
iron stores and risk of CHD [15]. For example, van der A DL
et al. and Sun et al. reported lack of association between serum
ferritin and CHD in women [16,17]. Similarly, Sempos et al.,
Knuiman et al. and Galan et al. found no association between
serum levels of ferritin and risk of CHD in both men and women
[18–20]. It is important to mention that most of the studies
examining the relationship of body iron stores and the risk of
CHD used serum ferritin as the clinical marker of body iron status
[4,11–14,16–23], however, in inflammatory conditions such as
AMI, serum ferritin levels have been known to be elevated with
concomitant decrease in serum iron [24], therefore, ferritin alone
may not be an authentic clinical biomarker for iron status in AMI.
On the other hand, sTfR as an index of tissue iron needs would
not be influenced by the acute phase response, and perhaps, would
provide better assessment of body iron status along with serum
ferritin as a marker of tissue iron stores [25]. A ratio of sTfR to
ferritin would, therefore, be a more reliable biomarker for body
iron status even in an inflammatory condition, and therefore this
study investigates the relationship of body iron stores with the risk
of premature AMI.
Premature CAD is quite common in Pakistani population. A
study from Karachi revealed that 16% of all the patients with AMI
admitted to the Aga Khan University Hospital between January
2000–December 2002 were below the age of 45 years and 93% of
them were men [26]. Besides genetic predisposition to developing
CAD [27], dietary patterns have also been shown to be associated
with the risk of AMI in this population [28,29]. Western dietary
pattern involving high consumption of red meat has been found to
be associated with increased risk of AMI [28]. Since red meat is
PLOS ONE | www.plosone.org
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study. Tuomainen et al. have emphasized to include the
information about users and nonusers of aspirin and antioxidants
in studies concerning role of body iron stores in CHD because
supplementation of these drugs could antagonize the riskincreasing effect of high iron stores [2]. Lack of information
about the use of antioxidant vitamins and aspirin in the study
population could be considered as another limitation of this study.
Mean levels of total cholesterol, triglycerides and LDL-cholesterol
were significantly lower in the study patients compared to controls;
probably due to anti-lipid medications. Absence of information
about the use of these medications is yet another limitation of this
study. All of the blood samples from the patients were obtained
within 24 hours of hospital admission. Since ferritin levels begin to
increase on day 2 following AMI [36], it would be reasonable to
assume that increased serum ferritin levels in AMI patients reflect
body iron stores without any significant contribution from acute
phase response. Measurement of serum levels of acute phase
reactants in AMI patients could have been helpful, however,
determination of markers of inflammation was not part of the
study protocol and this would also remain a limitation of the
present study. Despite these limitations, the present study did show
an association of body iron stores with the risk of premature AMI
in a Pakistani population. While such an association has been
shown in adult Finnish men up to the age of 60 years [2], our study
shows this relationship in relatively younger people (less than 45
years old) including both men and women. Our results, however,
are different from those reported by Sun et al. who have shown
lack of association between excessive body iron stores and CHD in
female registered nurses in USA aged 30–55 years [17]. Similarly,
in a German population serum concentrations of sTfR and ferritin
were not found to be associated with CAD [37]. On the basis of
these observations, it can be deduced that the relationship of body
iron status with CHD could vary from one population to another.

More data are, however, needed to further elucidate this
relationship, especially in South Asian population which has the
highest known rate of CAD [38,39]. The mechanism by which
high iron body status could be contributing to increased risk of
AMI merits some discussion. It could be due to increased
oxidation of LDL-cholesterol [21], increased oxidative damage
[40], the promotion of lipid peroxidation, enhanced reperfusion
injury and atherogenic properties [13], increased proliferation of
vascular smooth muscle cells [41], or it could be because of the
combination of all these along with other risk factors for CHD
such as hypertension, inflammation and hyperhomocysteinemia
which are highly prevalent in Pakistani population [3,42].

Conclusions
In an age and gender-matched case control study, high body
iron status (as determined by the ratio of concentrations of sTfR to
ferritin) has been found to be associated with increased risk of
premature AMI in a Pakistani population.
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